218 related articles for article (PubMed ID: 31272105)
1. Loss of FLCN inhibits canonical WNT signaling via TFE3.
Kennedy JC; Khabibullin D; Hougard T; Nijmeh J; Shi W; Henske EP
Hum Mol Genet; 2019 Oct; 28(19):3270-3281. PubMed ID: 31272105
[TBL] [Abstract][Full Text] [Related]
2. Birt-Hogg-Dube syndrome is a novel ciliopathy.
Luijten MN; Basten SG; Claessens T; Vernooij M; Scott CL; Janssen R; Easton JA; Kamps MA; Vreeburg M; Broers JL; van Geel M; Menko FH; Harbottle RP; Nookala RK; Tee AR; Land SC; Giles RH; Coull BJ; van Steensel MA
Hum Mol Genet; 2013 Nov; 22(21):4383-97. PubMed ID: 23784378
[TBL] [Abstract][Full Text] [Related]
3. New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome.
Kennedy JC; Khabibullin D; Boku Y; Shi W; Henske EP
Semin Respir Crit Care Med; 2020 Apr; 41(2):247-255. PubMed ID: 32279295
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndrome.
Chu L; Luo Y; Chen H; Miao Q; Wang L; Moats R; Wang T; Kennedy JC; Henske EP; Shi W
Thorax; 2020 Jun; 75(6):486-493. PubMed ID: 32238524
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue.
Wada S; Neinast M; Jang C; Ibrahim YH; Lee G; Babu A; Li J; Hoshino A; Rowe GC; Rhee J; Martina JA; Puertollano R; Blenis J; Morley M; Baur JA; Seale P; Arany Z
Genes Dev; 2016 Nov; 30(22):2551-2564. PubMed ID: 27913603
[TBL] [Abstract][Full Text] [Related]
6. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
Schmidt LS
Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization.
Hong SB; Oh H; Valera VA; Baba M; Schmidt LS; Linehan WM
PLoS One; 2010 Dec; 5(12):e15793. PubMed ID: 21209915
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dubé syndrome.
Hoshika Y; Takahashi F; Togo S; Hashimoto M; Nara T; Kobayashi T; Nurwidya F; Kataoka H; Kurihara M; Kobayashi E; Ebana H; Kikkawa M; Ando K; Nishino K; Hino O; Takahashi K; Seyama K
Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27905298
[TBL] [Abstract][Full Text] [Related]
9. FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.
Isono Y; Furuya M; Kuwahara T; Sano D; Suzuki K; Jikuya R; Mitome T; Otake S; Kawahara T; Ito Y; Muraoka K; Nakaigawa N; Kimura Y; Baba M; Nagahama K; Takahata H; Saito I; Schmidt LS; Linehan WM; Kodama T; Yao M; Oridate N; Hasumi H
Biochem Biophys Res Commun; 2020 Feb; 522(4):931-938. PubMed ID: 31806376
[TBL] [Abstract][Full Text] [Related]
10. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
11. Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.
Tee AR; Pause A
Fam Cancer; 2013 Sep; 12(3):367-72. PubMed ID: 23096221
[TBL] [Abstract][Full Text] [Related]
12. TFEB and TFE3 drive kidney cystogenesis and tumorigenesis.
Di Malta C; Zampelli A; Granieri L; Vilardo C; De Cegli R; Cinque L; Nusco E; Pece S; Tosoni D; Sanguedolce F; Sorrentino NC; Merino MJ; Nielsen D; Srinivasan R; Ball MW; Ricketts CJ; Vocke CD; Lang M; Karim B; Lanfrancone L; Schmidt LS; Linehan WM; Ballabio A
EMBO Mol Med; 2023 May; 15(5):e16877. PubMed ID: 36987696
[TBL] [Abstract][Full Text] [Related]
13. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome.
Nishii T; Tanabe M; Tanaka R; Matsuzawa T; Okudela K; Nozawa A; Nakatani Y; Furuya M
Pathol Int; 2013 Jan; 63(1):45-55. PubMed ID: 23356225
[TBL] [Abstract][Full Text] [Related]
14. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
15. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome.
Napolitano G; Di Malta C; Esposito A; de Araujo MEG; Pece S; Bertalot G; Matarese M; Benedetti V; Zampelli A; Stasyk T; Siciliano D; Venuta A; Cesana M; Vilardo C; Nusco E; Monfregola J; Calcagnì A; Di Fiore PP; Huber LA; Ballabio A
Nature; 2020 Sep; 585(7826):597-602. PubMed ID: 32612235
[TBL] [Abstract][Full Text] [Related]
16. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.
Baba M; Keller JR; Sun HW; Resch W; Kuchen S; Suh HC; Hasumi H; Hasumi Y; Kieffer-Kwon KR; Gonzalez CG; Hughes RM; Klein ME; Oh HF; Bible P; Southon E; Tessarollo L; Schmidt LS; Linehan WM; Casellas R
Blood; 2012 Aug; 120(6):1254-61. PubMed ID: 22709692
[TBL] [Abstract][Full Text] [Related]
17. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
[TBL] [Abstract][Full Text] [Related]
18. Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dubé syndrome: a case report.
Furuya M; Kobayashi H; Baba M; Ito T; Tanaka R; Nakatani Y
BMC Med Genomics; 2018 May; 11(1):42. PubMed ID: 29720200
[TBL] [Abstract][Full Text] [Related]
19. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.
Clausen L; Stein A; Grønbæk-Thygesen M; Nygaard L; Søltoft CL; Nielsen SV; Lisby M; Ravid T; Lindorff-Larsen K; Hartmann-Petersen R
PLoS Genet; 2020 Nov; 16(11):e1009187. PubMed ID: 33137092
[TBL] [Abstract][Full Text] [Related]
20. Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines.
Glykofridis IE; Henneman AA; Balk JA; Goeij-de Haas R; Westland D; Piersma SR; Knol JC; Pham TV; Boekhout M; Zwartkruis FJT; Wolthuis RMF; Jimenez CR
Mol Cell Proteomics; 2022 Sep; 21(9):100263. PubMed ID: 35863698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
